Supine or sitting? Economic considerations regarding patient position during plasma metanephrine analysis for the exclusion of chromaffin tumours

Affiliations

Comment

Vasileios Chortis et al. Clin Endocrinol (Oxf). 2015 Mar.

. 2015 Mar;82(3):462-3.

doi: 10.1111/cen.12587. Epub 2014 Sep 25.

¹ School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, UK. v.chortis@bham.ac.uk.

No abstract available

Comment in

Supine or Sitting? Economic and other considerations for use of plasma metanephrines for diagnosis of phaeochromocytoma.
Eisenhofer G, Därr R, Pamporaki C, Peitzsch M, Bornstein S, Lenders JW. Eisenhofer G, et al. Clin Endocrinol (Oxf). 2015 Mar;82(3):463-4. doi: 10.1111/cen.12602. Epub 2014 Nov 4. Clin Endocrinol (Oxf). 2015. PMID: 25186957 No abstract available.
Supine or sitting? the voice of the patient stakeholders: economics vs clinically and medically sound.
Sussman I, Rothwell T, Wilson A. Sussman I, et al. Clin Endocrinol (Oxf). 2015 Mar;82(3):464-5. doi: 10.1111/cen.12624. Epub 2014 Oct 29. Clin Endocrinol (Oxf). 2015. PMID: 25265273 No abstract available.
Supine or sitting plasma metanephrine screening? A unifying solution for patients and doctors.
Chortis V, Bancos I, Crowley RK, Arlt W. Chortis V, et al. Clin Endocrinol (Oxf). 2015 May;82(5):776-7. doi: 10.1111/cen.12659. Epub 2014 Dec 22. Clin Endocrinol (Oxf). 2015. PMID: 25376196 No abstract available.

Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions.
Därr R, Pamporaki C, Peitzsch M, Miehle K, Prejbisz A, Peczkowska M, Weismann D, Beuschlein F, Sinnott R, Bornstein SR, Neumann HP, Januszewicz A, Lenders J, Eisenhofer G. Därr R, et al. Clin Endocrinol (Oxf). 2014 Apr;80(4):478-86. doi: 10.1111/cen.12327. Epub 2013 Oct 17. Clin Endocrinol (Oxf). 2014. PMID: 24102244 Clinical Trial.